Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Punekar, Yogesh Suresh
62  Ergebnisse:
Personensuche X
?
1

Correction to: Comparative efficacy, safety and durability ..:

Nickel, Katharina ; Halfpenny, Nicholas J. A. ; Snedecor, Sonya J..
BMC Infectious Diseases.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
2

Comparative efficacy, safety and durability of dolutegravir..:

Nickel, Katharina ; Halfpenny, Nicholas J. A. ; Snedecor, Sonya J..
BMC Infectious Diseases.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
3

Improving access to antiretrovirals in China: economic anal..:

Punekar, Yogesh Suresh ; Guo, Na ; Tremblay, Gabriel...
Cost Effectiveness and Resource Allocation.  17 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
4

Cost-Effectiveness of Dolutegravir as a First-Line Treatmen..:

Tremblay, Gabriel ; Chounta, Vasiliki ; Piercy, James...
Value in Health Regional Issues.  16 (2018)  - p. 74-80 , 2018
Link: https://doi.org/10.1016/..
 
?
5

Non-persistence and non-adherence to long-acting COPD medic..:

Mueller, Sabrina ; Wilke, Thomas ; Bechtel, Benno...
Respiratory Medicine.  122 (2017)  - p. 1-11 , 2017
Link: https://doi.org/10.1016/..
 
?
6

Systematic review of the association between exercise tests..:

Punekar, Yogesh Suresh ; Riley, John H. ; Lloyd, Emily..
International Journal of Chronic Obstructive Pulmonary Disease.  12 (2017)  - p. 2487-2506 , 2017
Link: https://doi.org/10.2147/..
 
?
7

Rescue medication use as a patient-reported outcome in COPD..:

Punekar, Yogesh Suresh ; Sharma, Sheetal ; Pahwa, Ankit...
Respiratory Research.  18 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
8

Prevalence and Burden of Dyspnoea Among Patients with Chron..:

Punekar, Yogesh Suresh ; Mullerova, Hana ; Small, Mark...
Pulmonary Therapy.  2 (2016)  1 - p. 59-72 , 2016
Link: https://doi.org/10.1007/..
 
?
9

Characteristics, disease burden and costs of COPD patients ..:

Punekar, Yogesh Suresh ; Landis, Sarah H ; Wurst, Keele.
Respiratory Research.  16 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
?
10

Systematic Review of Humanistic and Economic Burden of Symp..:

Srivastava, Kunal ; Thakur, Deepika ; Sharma, Sheetal.
PharmacoEconomics.  33 (2015)  5 - p. 467-488 , 2015
Link: https://doi.org/10.1007/..
 
?
11

Cost-effectiveness of umeclidinium/vilanterol combination t..:

Punekar, Yogesh Suresh ; Roberts, Graeme ; Ismaila, Afisi.
Cost Effectiveness and Resource Allocation.  13 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
?
12

Treatment Evolution after COPD Diagnosis in the UK Primary ..:

Wurst, Keele E. ; Punekar, Yogesh Suresh ; Shukla, Amit.
PLoS ONE.  9 (2014)  9 - p. e105296 , 2014
Link: https://doi.org/10.1371/..
 
?
13

Cost effectiveness of golimumab for the treatment of active..:

Cummins, Ewen ; Asseburg, Christian ; Prasad, Manishi..
The European Journal of Health Economics.  13 (2012)  6 - p. 801-809 , 2012
Link: https://www.jstor.org/st..
 
?
14

Cost effectiveness of golimumab for the treatment of active..:

Cummins, Ewen ; Asseburg, Christian ; Prasad, Manishi..
The European Journal of Health Economics.  13 (2011)  6 - p. 801-809 , 2011
Link: https://doi.org/10.1007/..
 
?
15

Cost-effectiveness of infliximab for the treatment of activ..:

Cummins, Ewen ; Asseburg, Christian ; Punekar, Yogesh Suresh...
Value in Health.  14 (2011)  1 - p. 15-23 , 2011
Link: https://doi.org/10.1016/..
 
1-15